A multicenter, double-blind, randomized, phase 3 study to compare the safety and efficacy of intravenous CXA 201 and intravenous Levofloxacin in complicated Urinary Tract Infection, including Pyelonephritis
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest